Cleared Special

K120865 - RSCRIBE ELECTROCARDIOGRAPH

K120865 is the FDA 510(k) clearance for RSCRIBE ELECTROCARDIOGRAPH by Mortara Instrument, Inc.. It is a Class 2 Cardiovascular device (product code DPS) cleared through the Special 510(k) pathway after a 119-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2012
Decision
119d
Days
Class 2
Risk

K120865 is an FDA 510(k) clearance for the RSCRIBE ELECTROCARDIOGRAPH. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Mortara Instrument, Inc. (Milwaukee, US). The FDA issued a Cleared decision on July 19, 2012 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Mortara Instrument, Inc. devices

Submission Details

510(k) Number K120865 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 2012
Decision Date July 19, 2012
Days to Decision 119 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 125d · This submission: 119d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 220
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K120865.
CP150 ELECTROCARDIOGRAPH
K131573 · Welch Allyn, Inc. · Jul 2013
QT GUARD PLUS ANALYSIS SYSTEM
K120770 · Ge Medical Systems Information Technologies · Dec 2012
ELI 280 ELECTROCARDIOGRAPH
K122073 · Mortara Instrument, Inc. · Aug 2012
PAGEWRITER TC 20, 30, 50, 70
K113144 · Philips Medical Systems · Apr 2012
ELECTROCARDIOGRAPH
K120188 · Edan Instruments, Inc. · Mar 2012
ACG-8511 PORTABLE ECG MONITOR
K110328 · Andon Health Co, Ltd. · Jul 2011